Clinical Trial Update: Development of PK/PD Model for Individualized Propofol Dosing

View source ↗

Summary

The study reports completion of development of a PK/PD model to enable individualized propofol dosing in obese patients undergoing elective surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• PROPOFOL (Propofol)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Obesity, Elective Surgery | Status: COMPLETED